Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Market Size Estimates For The Montelukast Sodium Market?

The market for montelukast sodium has significantly expanded in the past few years. The market projections show an increase from $3.86 billion in 2024 to $4.2 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.9%. The historical growth in this market can be linked to factors such as rising incidence of respiratory ailments, an expanding aging populace, the escalation of air pollution, raised consciousness and education, and advancements in emerging markets.

In the ensuing years, the montelukast sodium market is predicted to witness significant expansion. Its growth is estimated to reach “$5.89 billion in 2029”, with a compound annual growth rate (CAGR) of 8.8%. The expected expansion during the forecasted period can be tied to factors such as approval and launch, clinical research, expiration of patents, changes in regulations, and doctor’s prescribing habits. The prominent trends for the forecast period encompass heightened competition in the generic sector, a move towards combination therapies, growth in developing markets, concentration on usage in children, and an emphasis on digital health solutions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

Which Industry Forces Are Driving The Montelukast Sodium Market Forward?

The rise in asthma occurrences is predicted to fuel the expansion of the montelukast sodium market. Asthma, a persistent respiratory condition characterized by inflammation and narrowing of the airways, leads to recurring episodes of wheezing, shortness of breath, chest tightness, and coughing. Factors such as environmental pollution, exposure to allergens, genetic susceptibility, urbanization, lifestyle changes and respiratory infections are leading to an increased incidence of asthma. Montelukast sodium acts as a leukotriene receptor antagonist in asthma treatment, helping to keep asthma symptoms under control by impeding the effects of leukotrienes which cause airway inflammation and narrowing. For example, the American Lung Association, a voluntary health organization based in the US, stated in July 2024 that roughly 44.2 million Americans, making up 13.5% of the population, had been diagnosed with asthma by a medical professional. Consequently, this rise in asthma prevalence is stimulating the growth of the montelukast sodium market.

How Is The Global Montelukast Sodium Market Broken Down By Segment?

The montelukast sodium market covered in this report is segmented –

1) By Product: Crystal-like, Form-less Or Amorphous

2) By Dosage Form: Tablets, Oral Solutions

3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

Subsegments:

1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium

2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium

Which Trends Are Likely To Redefine Growth Paths In The Montelukast Sodium Market?

Leading firms in the montelukast sodium market are innovating and introducing new products like OTC generic drugs to provide more accessible treatment alternatives for individuals dealing with asthma and allergic rhinitis. OTC generic medications are pharmaceuticals that can be purchased without a prescription, typically available in pharmacies or retail establishments. For example, in July 2022, Fexofenadine HCL 180 mg and Pseudoephedrine HCl 240 mg got launched in the US by Dr. Reddy’s Laboratories, a pharmaceutical firm based in India. This drug is developed for providing temporary relief from nasal and sinus congestion due to colds or allergies. Comparable to Allegra-D 24 HR, it merges an antihistamine and a nasal decongestant to relieve symptoms like a runny nose, sneezing, itchy eyes and throat. It comes in packs of 5, 10, and 15, providing a high-quality, budget-friendly solution for individuals seeking relief from discomfort related to upper respiratory issues.

Which Firms Are Making The Biggest Impact In The Montelukast Sodium Market?

Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Montelukast Sodium Market?

North America was the largest region in the montelukast sodium market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16123&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model